Evidence map›Paper›PMID 38311729›Full record

ArticleJournal of neuroengineering and rehabilitation2024

Transforming modeling in neurorehabilitation: clinical insights for personalized rehabilitation.

David J Lin, Deborah Backus, Stuti Chakraborty, Sook-Lei Liew, Francisco J Valero-Cuevas, Carolynn Patten, R James Cotton

Abstract readLetter
In one paragraph

Article in Journal of neuroengineering and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David J LinDepartment of Neurology, Division of Neurocritical Care and Stroke Service, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. dlin7@mgh.harvard.edu.
Deborah BackusCrawford Research Institute, Shepherd Center, Atlanta, GA, USA.
Stuti ChakrabortyChan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, USA.
Sook-Lei LiewChan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, USA.
Francisco J Valero-CuevasDivision of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA, USA.
Carolynn PattenDepartment of Physical Medicine and Rehabilitation, UC Davis School of Medicine, Sacramento, CA, USA.
R James CottonDepartment of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL, USA.

Funding

Resource DiscoveryP41EB019936 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MARYANN E MARTONE · 2016 to 2026
$15.2M
Supplement to Effects of global brain health on sensorimotor recovery after strokeR01NS115845 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEW, SOOK-LEI · 2020 to 2024
$3.2M
Building a data science workforce to improve the reproducibility of rehabilitation researchR25HD105583 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI David Nelson Kennedy, Sook-Lei Liew · 2022 to 2026
$812k
Deconstructing Post-Stroke Hemiparesis for Precision NeurorehabilitationIK2RX004237 · VA · PROVIDENCE VA MEDICAL CENTER · PI LIN, DAVID J · 2022 to 2025
–
NIBIB NIH HHS P41 EB019936NICHD NIH HHS R25 HD105583NINDS NIH HHS R01 NS115845RRD VA IK2 RX004237
6 · The paper itself

Abstract

Practicing clinicians in neurorehabilitation continue to lack a systematic evidence base to personalize rehabilitation therapies to individual patients and thereby maximize outcomes. Computational modeling- collecting, analyzing, and modeling neurorehabilitation data- holds great promise. A key question is how can computational modeling contribute to the evidence base for personalized rehabilitation? As representatives of the clinicians and clinician-scientists who attended the 2023 NSF DARE conference at USC, here we offer our perspectives and discussion on this topic. Our overarching thesis is that clinical insight should inform all steps of modeling, from construction to output, in neurorehabilitation and that this process requires close collaboration between researchers and the clinical community. We start with two clinical case examples focused on motor rehabilitation after stroke which provide context to the heterogeneity of neurologic injury, the complexity of post-acute neurologic care, the neuroscience of recovery, and the current state of outcome assessment in rehabilitation clinical care. Do we provide different therapies to these two different patients to maximize outcomes? Asking this question leads to a corollary: how do we build the evidence base to support the use of different therapies for individual patients? We discuss seven points critical to clinical translation of computational modeling research in neurorehabilitation- (i) clinical endpoints, (ii) hypothesis- versus data-driven models, (iii) biological processes, (iv) contextualizing outcome measures, (v) clinical collaboration for device translation, (vi) modeling in the real world and (vii) clinical touchpoints across all stages of research. We conclude with our views on key avenues for future investment (clinical-research collaboration, new educational pathways, interdisciplinary engagement) to enable maximal translational value of computational modeling research in neurorehabilitation.

Indexed as

Neurological RehabilitationStrokeStroke RehabilitationHumansOutcome Assessment, Health CareClinical translationComputational modelingNeurorecoveryNeurorehabilitationRehabilitation engineering

Identifiers

PMID38311729
PMCPMC10840185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.